Biotechnological research on the most dangerous pathogens: Challenges for risk governance and safety management

Safety Science

Volumn 47, Issue 6, 2009, Pages 890-898

  Baram, Michael ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Accidental release; Biosafety; Biotechnology; Bioterrorism; Disease epidemic; Emergency response; Environmental assessment; Incident reporting; Infectious disease; Laboratory safety; Near miss; Organizational learning; Pathogens; Public safety; Risk scenarios; Safety culture; Safety management; Select agents; Self regulation; Siting; Workplace safety

Indexed keywords

ACCIDENTAL RELEASE; BIOSAFETY; BIOTERRORISM; EMERGENCY RESPONSE; ENVIRONMENTAL ASSESSMENT; INCIDENT REPORTING; INFECTIOUS DISEASE; LABORATORY SAFETY; NEAR MISS; ORGANIZATIONAL LEARNING; PUBLIC SAFETY; RISK SCENARIOS; SAFETY CULTURE; SAFETY MANAGEMENT; SELECT AGENTS; SELF REGULATION; SITING; WORKPLACE SAFETY;

ACCIDENTS; BIOTECHNOLOGY; DEREGULATION; ENVIRONMENTAL REGULATIONS; KNOWLEDGE MANAGEMENT; LABORATORIES; PATHOGENS; RISK PERCEPTION;

OCCUPATIONAL RISKS;

ACCIDENT; ARTICLE; AUTOREGULATION; BIOLOGICAL WARFARE; BIOTECHNOLOGICAL PROCEDURES; DECISION MAKING; EMERGENCY CARE; EPIDEMIC; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION; LABORATORY PERSONNEL; LAW SUIT; LETHALITY; MANAGEMENT; MEDICAL RESEARCH; ORGANIZATION; PATHOGENESIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK MANAGEMENT; SAFETY;

EID: 63749133141     PISSN: 09257535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ssci.2008.10.010     Document Type: Article

References (47)

1. Allen, K., 2006a. Allen v. Boston Redevelopment Authority, Superior Court, MA, 21 Mass. Law Reporter 324, August 2.
2. Allen, K., 2006b. Allen v. NIH et al., US District Court, D. Mass., C.A. No. 06-10877-PBS, October 20.
3. Allen, K., 2007. Allen v. Boston Redevelopment Authority, Supreme Judicial Court, MA, SJC-09960, December 13.
4. Balmer A., and Martin P. Synthetic Biology (2008), Institute for Science and Society, University of Nottingham May
5. Baram M. Shame, blame and liability: why safety management suffers organizational learning disabilities. In: Hale A., and Wilpert B. (Eds). After the Event: From Accident to Organizational Learning (1997), Pergamon
6. Baram M. Making clinical trials safer for human subjects. American Journal of Law and Medicine 27 2-3 (2001)
7. Baram, M., 2007. Statement to NIH: Draft Supplementary Risk Assessments and Site Suitability Analyses for the NEID Laboratory at Boston University, November 28.
8. Baram, M.S., 2008. Nothing More Than Duct Tape Used to Seal Door at Biosafety Lab, ABC News, June 25. (accessed 26.06.08).
9. Baram M., and Schoebel M. Safety culture and behavioral change at the workplace. Safety Science 45 6 (2007) 631-636
10. Bayer, R., Colgrove, J., 2008. Bioterrorism, health and the law. Health Affairs Journal. .
11. Besser, R., 2007. Centers for Disease Control Report on Oversight of Select Agents by the Centers for Disease Control, Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, US House of Representatives, October 4.
12. Breyer S. Active Liberty (2005), Vintage Books
13. Boston Globe, 2005. Neb.University Delays Probe into Tularemia Infections at BU Lab, May 16. .
14. Boston University, 2007. Draft Supplementary Risk Assessments and Suitability Analyses for the National Emerging Infectious Diseases Laboratory, Boston University and NIH, July.
15. CDC, 2001. Biosafety in Microbiological and Biomedical Laboratories (BMBL), fourth ed. Centers for Disease Control. .
16. CIDRAP, 2007. CDC Details Problems at Texas A & M Biodefense Lab, Center for Infectious Disease Research and Policy, University of Minnesota, September 5. .
17. Corrigan, D., 2004. Deputy Inspector General, Summary Report on Biosecurity at Universities (A-04-04-02000), Department of Health and Human Services, March 25.
18. EU, 2007. Commission Adopts a Green Paper on Bio-Preparedness, Press Release Reference No. IP/07/1065, European Union, July 11.
19. GAO, 2007a. Biological Research Laboratories: Issues Associated with the Expansion of Laboratories Funded by the National Institute of Allergy and Infectious Diseases, GAO -07-333R, US Government Accountability Office, February 22.
20. GAO, 2007b. High Containment Biosafety Laboratories: Preliminary Observations on the Oversight and Proliferation of BSL-3 and BSL-4 Laboratories in the United States, GAO-08-108T, US Government Accountability Office, October 4.
21. Gilbert, N., 2008. Coming soon? Guardian, April 22. (accessed 24.04.08).
22. HHS, undated. Project Bioshield Notices and Reports at Department of Health and Human Services Website. (accessed 30.09.08).
23. HHS, 1999. Biosafety in Microbiological and Biomedical Laboratories, fourth ed., US Department of Health and Human Services, April.
24. HHS, 2008. Guidance on Allocating and Targeting Pandemic Influenza Vaccine, US Department of Health and Human Services, US Department of Homeland Security.
25. Kahn L. Biodefense research: can secrecy and safety co-exist?. Biosecurity and Bioterrorism: Biodefense Strategy, Practice and Science 2 2 (2004)
26. Kaiser, J., 2007. Proliferation of Biosafety Labs Poses Its Own Risks, Congress Told, ScienceNOW, 4 October. .
27. Klempner M., Unnasch T., and Hu L. Taking a bite out of vector-transmitted diseases. New England Journal of Medicine 365 25 (2007) 2567-2569
28. Levinson, D., 2008. Inspector General, Summary Report on State, Local, Private and Commercial Laboratories' Compliance with Select Agent Regulations (A-04-06-01033), Department of Health and Human Services, January 9.
29. Lloyd's. Scanning the Risk Horizon for Emerging Threats, Press Release (2008), Lloyd's Worldwide News Centre April 8
30. Miller, J., 2004. New Germ Labs Stir Debate Over Secrecy and Safety, New York Times, February 10. .
31. MEPA, 1972. Massachusetts Environmental Policy Act, M.G.L.c. 30, Sections 61 Through 62H.
32. NAS, 2004. Biotechnology Research in an Age of Terrorism, National Academy of Sciences.
33. NAS, 2007. Report of the Committee on Technical Input on Any Additional Studies to Assess Risk Associated with Operation of the National Emerging Infectious Diseases Laboratory, Boston University, November 29.
34. NEPA, 1970. National Environmental Policy Act, 42 U.S.C. 4321.
35. NIH, 2007. NIH Guidelines for Research Involving Recombinant DNA Molecules, National Institutes of Health, Department of Health and Human Services.
36. NSABB, 2007. Proposed Framework for Oversight of Dual Use Life Sciences Research: Strategies for Minimizing the Potential Misuse of Research Information, National Science Advisory Board for Biosecurity, June.
37. OSHA Regulation on Blood-Borne Pathogens, 29 Code of Federal Regulations 1910.1030. .
38. Pearson, A., 2007. Center for Arms Control and Non-Proliferation, Statement to House Energy and Commerce Committee, Subcommittee on Oversight and Investigations, Hearing on Germs, Viruses and Secrets, US Congress, October 4.
39. Progressive Newswire, 2008. (accessed 15 April).
40. RNAAS, 2007. A Code of Conduct for Biosecurity, Royal Netherlands Academy of Arts and Sciences, August.
41. Ramshaw, E., 2007. A & M Lab Employee Lacked Clearance in Bioagent Case. Dallas Morning News, July 28.
42. Reilly, A., 2008. Biolab Follies. The Phoenix. (accessed 2 April).
43. Sunshine Project, 2005. News Release: Boston University Lab-Acquired Tularemia, March 11. .
44. UPMC, 2007. Center for Biosecurity, Meeting Report and Recommendations on High Containment Biodefense Research Laboratories, University of Pittsburgh Medical Center. .
45. Ware, P., 2008. Ware, Infectious Diseases, Occupational Safety and Health Reporter, vol. 38, no. 36. Bureau of National Affairs, pp. 703-704.
46. WHO, 2005. Developing Laboratory Partnerships to Detect Infections and Prevent Epidemics, World Health Organization.
47. Wilpert B., and Klumb P. Potentials and limitations of safety culture. In: Wilpert B., Ulrik Qvale T., and Qvale T. (Eds). Reliability and Safety in Hazardous Work Systems (1993), Psychology Press 8-9